1. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pineros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941-53.
2. Travis WD. Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas. Mod Pathol. 2012;25 Suppl 1:S18-30.
3. Cai H, Wang H, Li Z, Lin J, Yu J. The prognostic analysis of different metastatic patterns in extensive-stage small-cell lung cancer patients: a large population-based study. Future Oncol. 2018;14(14):1397-407.
4. Zhao H, Ren D, Liu H, Chen J. Comparison and discussion of the treatment guidelines for small cell lung cancer. Thorac Cancer. 2018;9(7):769-74.
5. Horn L, Reck M, Spigel DR. The Future of Immunotherapy in the Treatment of Small Cell Lung Cancer. Oncologist. 2016;21(8):910-21.
6. Li J, Zhu H, Sun L, Xu W, Wang X. Prognostic value of site-specific metastases in lung cancer: A population based study. J Cancer. 2019;10(14):3079-86.
7. Ren Y, Dai C, Zheng H, Zhou F, She Y, Jiang G, et al. Prognostic effect of liver metastasis in lung cancer patients with distant metastasis. Oncotarget. 2016;7(33):53245-53.
8. Scosyrev E, Messing J, Noyes K, Veazie P, Messing E. Surveillance Epidemiology and End Results (SEER) program and population-based research in urologic oncology: an overview. Urol Oncol. 2012;30(2):126-32.
9. Li J, Liu F, Yu H, Zhao C, Li Z, Wang H. Different distant metastasis patterns based on tumor size could be found in extensive-stage small cell lung cancer patients: a large, population-based SEER study. PeerJ. 2019;7:e8163.
10. Wang X, Wang Z, Pan J, Lu ZY, Xu D, Zhang HJ, et al. Patterns of Extrathoracic Metastases in Different Histological Types of Lung Cancer. Front Oncol. 2020;10:715.
11. Bovi JA. Prevention of Brain Metastases. Front Neurol. 2018;9:758.
12. Takahashi T, Yamanaka T, Seto T, Harada H, Nokihara H, Saka H, et al. Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2017;18(5):663-71.
13. NICE Guideline Updates Team (UK). Evidence reviews for the clinical and cost-effectiveness of prophylactic cranial irradiation to prevent brain metastases in people with extensive SCLC: Lung cancer: diagnosis and management: Evidence review H. London: National Institute for Health and Care Excellence (UK); 2019.
14. Sharma S, McMillan MT, Doucette A, Cohen RB, Berman A, Levin W, et al. Effect of Prophylactic Cranial Irradiation on Overall Survival in Metastatic Small-Cell Lung Cancer: A Propensity Score-Matched Analysis. Clin Lung Cancer. 2018;19(3):260-9..
15. Soliman H, Ruschin M, Angelov L, Brown PD, Chiang VLS, Kirkpatrick JP, et al. Consensus Contouring Guidelines for Postoperative Completely Resected Cavity Stereotactic Radiosurgery for Brain Metastases. Int J Radiat Oncol Biol Phys. 2018;100(2):436-42.
16. Brown PD, Ballman KV, Cerhan JH, Anderson SK, Carrero XW, Whitton AC, et al. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC.3): a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol. 2017;18(8):1049-60.
17. Charpidou A, Tsagouli S, Gkiozos I, Grapsa D, Moutsos M, Kiagia M, et al. Bone metastases in patients with small cell lung carcinoma: rate of development, early versus late onset, modality of treatment, and their impact on survival. A single-institution retrospective cohort study. Clin Exp Metastasis. 2016;33(5):453-60.
18. Conen K, Hagmann R, Hess V, Zippelius A, Rothschild SI. Incidence and predictors of Bone Metastases (BM) and Skeletal-Related Events (SREs) in Small Cell Lung Cancer (SCLC): A Swiss patient cohort. J Cancer. 2016;7(14):2110-6.
19. Ettinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge DR, et al. Non-Small Cell Lung Cancer, Version 6.2015. J Natl Compr Canc Netw. 2015;13(5):515-24.
20. Nakagawa T, Okumura N, Ohata K, Igai H, Matsuoka T, Kameyama K. Postrecurrence survival in patients with stage I non-small cell lung cancer. Eur J Cardiothorac Surg. 2008;34(3):499-504.
21. Wang C, Yang C, Wang W, Xia B, Li K, Sun F, et al. A Prognostic Nomogram for Cervical Cancer after Surgery from SEER Database. J Cancer. 2018;9(21):3923-8.
22. Hou G, Zheng Y, Wei D, Li X, Wang F, Tian J, et al. Development and validation of a SEER-based prognostic nomogram for patients with bone metastatic prostate cancer. Medicine (Baltimore). 2019;98(39):e17197.
23. Xiao Z, Shi Z, Hu L, Gao Y, Zhao J, Liu Y, et al. A new nomogram from the SEER database for predicting the prognosis of gallbladder cancer patients after surgery. Ann Transl Med. 2019;7(23):738.
24. Wang Y, Zheng Q, Jia B, An T, Zhao J, Wu M, et al. Effects of Surgery on Survival of Early-Stage Patients With SCLC: Propensity Score Analysis and Nomogram Construction in SEER Database. Front Oncol. 2020;10:626.
25. Zhong J, Zheng Q, An T, Zhao J, Wu M, Wang Y, et al. Nomogram to predict cause-specific mortality in extensive-stage small cell lung cancer: A competing risk analysis. Thorac Cancer. 2019;10(9):1788-97.
26. Lu YJ, Yang Y, Yuan YH, Wang WJ, Cui MT, Tang HY, et al. A novel nomogram based on SEER database for the prediction of liver metastasis in patients with small-cell lung cancer. Ann Palliat Med. 2020;9(5):3123-37.
27. Gao H, Dang Y, Qi T, Huang S, Zhang X. Mining prognostic factors of extensive-stage small-cell lung cancer patients using nomogram model. Medicine (Baltimore). 2020;99(33):e21798.